Hbl Biotech Producer Company Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 27 Days
About Hbl Biotech Producer Company
Hbl Biotech Producer Company Limited (HBPCL) is a Private Limited Indian Non-Government Company incorporated in India on 20 January 2023 (Two years 27 days old ). Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kiran Marmat, Suresh Murade, Premsing Marmat, and Two other members serve as directors at the Company.
Company Details
-
Location
Aurangabad, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U01100MH2023PTC398012
-
Company No.
398012
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Jan 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Hbl Biotech Producer Company?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiran Marmat
|
Director | 20-Jan-2023 | Current |
|
Suresh Murade
|
Director | 20-Jan-2023 | Current |
|
Premsing Marmat
|
Director | 20-Jan-2023 | Current |
|
Jyoti Marmat
|
Director | 20-Jan-2023 | Current |
|
Kashabai Jakhad
|
Director | 20-Jan-2023 | Current |
Financial Performance of Hbl Biotech Producer Company.
Enhance accessibility to Hbl Biotech Producer Company's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hbl Biotech Producer Company?
Unlock access to Hbl Biotech Producer Company's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Hbl Biotech (Opc) Private LimitedKiran Marmat is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hbl Biotech Producer Company?
Hbl Biotech Producer Company has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hbl Biotech Producer Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hbl Biotech Producer Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.